Lam Research (LRCX) PT Raised to $95 at Nomura But Remains Sidelined

Go back to Lam Research (LRCX) PT Raised to $95 at Nomura But Remains Sidelined

Cowen Lifts PT on Lam Research (LRCX) to $100; Notes Strong Qtr., But WFE Run-Rate Not Sustainable

October 20, 2016 7:58 AM EDT

Cowen & Company lifts its price target on Outperform rated Lam Research (Nasdaq: LRCX) from $95 to $100 following Q1 results and outlook issued Wednesday night.

The firm commented today: LRCX continues to execute with incredible regularity and our new #s justify $100 target. On one... More

Lam Research (LRCX) PT Raised to $110 at RBC Capital

October 20, 2016 6:30 AM EDT

RBC Capital analyst Amit Daryanani reiterated an Outperform rating and lifted his price target on Lam Research (NASDAQ: LRCX) to $110.00 (from $105.00) following solid Q4 results and strong guidance.

Daryanani commented, "LRCX reported modest upside to Sept-qtr results, but guided Dec-qtr rev/EPS... More

Lam Research (LRCX) Tops Q1 EPS by 3c; Issues Solid Outlook

October 19, 2016 4:10 PM EDT

Lam Research (NASDAQ: LRCX) reported Q1 EPS of $1.81, $0.03 better than the analyst estimate of $1.78. Revenue for the quarter came in at $1.63 billion versus the consensus estimate of $1.63 billion.

GUIDANCE:

Lam Research sees Q2 EPS of $2.08-$2.28, which may not... More